Active Pharmaceutical Ingredient API News and Research

RSS

BAI and Novartis determine whether investigational drugs can prevent symptoms of Alzheimer's

Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.

15 Jul 2014

New important education initiative to help train pathology residents in clinical informatics

The widespread adoption of the electronic health record (EHR), spurred in large part by meaningful use and related federal programs, is changing the way health care providers interact with laboratory information. Now, more than ever, pathologists need to be well-versed in the field of clinical informatics in order to deliver high quality and cost-effective patient care.

9 Jul 2014

Mylan launches Telmisartan Tablets USP

Mylan Inc. today announced that it has launched Telmisartan Tablets USP, 20 mg, 40 mg and 80 mg, the generic version of Boehringer Ingelheim's Micardis® Tablets.

8 Jul 2014

Hospira acquires API manufacturing and R&D facilities from Orchid for about $218 million

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $218 million, after settling prior advances of approximately $30 million.

7 Jul 2014

New research project aims to tackle antibiotic resistance with inhalable nanotherapeutics

A new research project (PneumoNP) is aimed at tackling antibiotic resistance in respiratory tract infections via the use of inhalable nanotherapeutic compounds. Funded under the FP7 programme by the European Commission, the 4-year long PneumoNP project brings together top research institutes, universities, clinicians and enterprises from 6 EU member states.

28 Jun 2014

iGetBetter selects Validic platform to access data from broad range of biometric devices

iGetBetter, Inc., a supplier of post-acute care transition solutions, and Validic, the healthcare industry's premier technology platform for accessing digital health data, announced today that iGetBetter has selected the Validic platform to access data from a broad range of available biometric devices as part of its care transition solution focused on reducing readmissions.

10 Jun 2014

Mylan launches generic version of Bristol-Myers Squibb's Paraplatin Injection

Mylan Inc. today announced that it has launched Carboplatin Injection, 50 mg/5 ml, in multi-dose vials, which is the generic version of Bristol-Myers Squibb's Paraplatin® Injection.

9 Jun 2014

Transforming health care with data proves daunting

Speakers at Health Datapalooza, the annual convention for data geeks, doctors, researchers and patients, offered numerous examples of how people are trying to use data to make medical care safer, swifter and less expensive. But most of those projects are still works in progress.

5 Jun 2014

Mylan launches generic version of GlaxoSmithKline's Malarone Tablets

Mylan Inc. today announced that it has launched Atovaquone and Proguanil Hydrochloride Tablets, 62.5 mg/25 mg and 250 mg/100 mg, the generic version of GlaxoSmithKline's Malarone® Tablets.

29 May 2014

Half-life extension technology: an interview with Dermot Pearson, Novozymes Biopharma

A drug's half-life indicates how long a substance will remain active in the body. It is essentially the period of time that it takes for the concentration of the amount of the drug to be reduced by half, and therefore, determines how frequently a drug needs to be administered to maintain its therapeutic effect.

27 May 2014

Analytik announces UK and Ireland release of the SciAps Inspector 500 SWIR Raman for the pharmaceutical industry

Analytik, leading suppliers of innovative analytical instrumentation, announce the SciAps Inspector 500 SWIR Raman system for the pharmaceutical industry.

23 May 2014

St. Bernards Healthcare selects InteliChart's Enterprise Patient Portal for acute care facilities

InteliChart, a leading provider of patient engagement and health information exchange (HIE) technology, announced today that St. Bernards Healthcare, the largest healthcare integrated delivery network in northeastern Arkansas, has selected InteliChart's Enterprise Patient Portal to deliver a single portal solution for its system of acute and ambulatory care facilities.

6 May 2014

Teva announces positive results from pivotal Phase III study of hydrocodone bitartrate extended-release tablets

Teva Pharmaceutical Industries Ltd. today announced positive results from a pivotal Phase III study of hydrocodone bitartrate extended-release tablets designed with Teva's proprietary technology providing potential abuse-deterrent properties (CEP-33237).

30 Apr 2014

USPTO grants patent for low-cost dry powder inhaler to Hovione

Hovione announced today that the United States Patent and Trademark Office (USPTO) has granted a patent for a capsule-based, low-cost dry powder inhaler (DPI) to Hovione. This happened less than three years after the patent was filed and after just one Office Action - unusual speed for an inhaler application.

8 Apr 2014

GE Healthcare agrees to acquire CHCA Computer Systems

GE Healthcare announced today it has agreed to acquire CHCA Computer Systems Inc., an operating room (OR) management and analytics solutions provider, headquartered in Montreal, Canada. CHCA develops the Opera software application, which has helped increase productivity and patient satisfaction in the OR by providing real-time data to support the decision making and management of surgical procedures.

2 Apr 2014

AMRI signs definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals

AMRI today announced that it has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals, Inc. for $38.2 million in cash.

24 Mar 2014

Perrigo Company acquires basket of value-brand OTC products in Australia

Perrigo Company plc announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc. for $51 million in cash.

28 Feb 2014

TPI announces financial results for second quarter fiscal year 2014

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter fiscal year 2014.

14 Feb 2014

GE completes acquisition of API Healthcare

GE announced today it has completed the acquisition of API Healthcare, a healthcare workforce management solutions provider, headquartered in Hartford, WI.

13 Feb 2014

Cambrex fourth quarter sales increase 46.3% to $103 million

Cambrex Corporation reports results for the fourth quarter and full year ended December 31, 2013.

11 Feb 2014